EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Lenacapavir binding to immature Gag induces giant virions and causes protease-dependent inhibition of viral release

Wright Andrews Ofotsu Amesimeku iD, Yoshihiro Nakata, Nami Monde iD, Hiromi Terasawa iD, Hirotaka Ode iD, Hiroyuki Sasaki iD, Consolata Elias Rukondo iD, Takeshi Matsui, Perpetual Nyame iD, Md Jakir Hossain iD, Akatsuki Saito iD, Tomohiro Sawa iD und 4 weitere

Proceedings of the National Academy of Sciences · 2026

DOI: 10.1073/pnas.2609634123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Wright Andrews Ofotsu Amesimeku und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan. Hauptthemen laut MEDLINE: HIV-1, Virion, Virus Release, gag Gene Products, Human Immunodeficiency Virus. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED), MEXT | JSPS | Japan Society for the Promotion of Science London (JSPS), Takeda Science Foundation (TSF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lenacapavir (LEN), a potent capsid inhibitor, suppresses reverse transcription and nuclear import by disrupting capsid core formation in HIV type 1 (HIV-1). However, its effects on late-stage viral assembly remain unclear. Although p24 ELISA suggested that LEN substantially inhibited HIV-1, both RT-dPCR and Vpr-HiBiT assays indicated that suppression of viral release required relatively high LEN concentrations. This discrepancy was attributed to LEN-induced reduction in p24 solubility, leading to an overestimation of its inhibitory effect on viral release. In addition, excessive intracellular Gag processing by the viral protease was observed in the presence of LEN, which contributed to impaired viral release. Furthermore, LEN induced numerous abnormal, discrete clusters of Gag at the plasma membrane. Using mass photometry, which was applied to analyze HIV-1 particle sizes, and transmission electron microscopy, we identified heterogeneous LEN-induced viral-like particles (LENiVLPs; diameter >200 nm) containing both Gag and Env proteins. Although LENiVLPs retained membrane fusion capability, they were noninfectious owing to postentry defects that prevented viral replication. Thus, LEN binds to the precursor Gag and promotes aberrant particle formation, offering insights that could guide the development of next-generation LEN-based therapeutics targeting the late stages of the viral life cycle.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1VirionVirus Releasegag Gene Products, Human Immunodeficiency VirusHumansHIV ProteaseVirus AssemblyProtein BindingAcetamidesIndazoles

Stichwörter der Autor:innen

HIV-1LENiVLPslenacapavirmass photometryprotease

Substanzen

HIV Proteasegag Gene Products, Human Immunodeficiency ViruslenacapavirAcetamidesIndazoles

Autor:innen und Institutionen

  • Department of Microbiology, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
  • Department of Infectious Diseases and Immunology, Clinical Research Center, NHO Nagoya Medical Center, Nagoya 460-0001, Japan.
  • Laboratory for Evolutionary Cell Biology of the Skin, School of Bioscience and Biotechnology, Tokyo University of Technology, Tokyo 192-0982, Japan.
  • Frontier Science Research Center, University of Miyazaki, Miyazaki 889-2192, Japan.
  • Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-0811, Japan.
  • Department of Nursing, Kibi International University, Takahashi 716-8508, Okayama, Japan.

ORCID-Profile: Wright Andrews Ofotsu Amesimeku, Nami Monde, Hiromi Terasawa, Hirotaka Ode, Hiroyuki Sasaki, Consolata Elias Rukondo, Perpetual Nyame, Md Jakir Hossain, Akatsuki Saito, Tomohiro Sawa, Terumasa Ikeda, Yasumasa Iwatani, Kazuaki Monde

Förderung

  • Japan Agency for Medical Research and Development (AMED)
  • MEXT | JSPS | Japan Society for the Promotion of Science London (JSPS)
  • Takeda Science Foundation (TSF)
  • Mitsubishi Foundation (The Mitsubishi Foundation)

Zitieren

APA

Amesimeku, W. A. O., Nakata, Y., Monde, N., Terasawa, H., Ode, H., Sasaki, H., Rukondo, C. E., Matsui, T., Nyame, P., Hossain, M. J., Saito, A., Sawa, T., Ikeda, T., Maeda, Y., Iwatani, Y., & Monde, K. (2026). Lenacapavir binding to immature Gag induces giant virions and causes protease-dependent inhibition of viral release. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2609634123

Vancouver

Amesimeku WAO, Nakata Y, Monde N, Terasawa H, Ode H, Sasaki H, et al. Lenacapavir binding to immature Gag induces giant virions and causes protease-dependent inhibition of viral release. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2609634123

BibTeX
@article{Amesimeku2026,
  author = {Amesimeku, Wright Andrews Ofotsu and Nakata, Yoshihiro and Monde, Nami and Terasawa, Hiromi and Ode, Hirotaka and Sasaki, Hiroyuki and Rukondo, Consolata Elias and Matsui, Takeshi and Nyame, Perpetual and Hossain, Md Jakir and Saito, Akatsuki and Sawa, Tomohiro and Ikeda, Terumasa and Maeda, Yosuke and Iwatani, Yasumasa and Monde, Kazuaki},
  title = {Lenacapavir binding to immature Gag induces giant virions and causes protease-dependent inhibition of viral release},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  doi = {10.1073/pnas.2609634123}
}
Kostenlos starten →